newsfilter
← Latest News
GlobeNewswire·

Cassava Sciences Announces Over $125 Million Raised from Warrant Distribution

AUSTIN, Texas, May 08, 2024 (GLOBE NEWSWIRE) -- Cassava Sciences, Inc. (NASDAQ:SAVA) (the "Company"), a biotechnology company focused on Alzheimer's disease, today announced total gross proceeds of over $125 million